Bristol Myers Squibb Announced Aspire, A 10-year Strategy With An Aim To Reach Over 200,000 Patients In Low-And Middle-Income Countries By 2033, As Part Of Aspire, Bristol Myers Is Developing Tailored Strategies To Increase Affordability And Availability